ANSM) ; les anticoagulants en France en 2012: Etat des lieux et surveillance ,
Existe-t-il une typologie des actes éffectués en médecine générale ?, La revue du praticien, vol.18, pp.781-784, 2004. ,
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians, Thrombosis Research, vol.108, issue.1, pp.3-13, 2002. ,
DOI : 10.1016/S0049-3848(02)00387-0
Surgery and invasive procedures in patient on long-term treatment with oral direct thrombin or factor Xa inhibitors. Annale Françaises d'anesthésie et de, Réanimation, vol.30, pp.645-650, 2011. ,
European Heart Rhythm Association. Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation, European Heart Journal, vol.15, pp.625-651, 2013. ,
Perioperative Management of Patients Receiving Oral Anticoagulants, Archives of Internal Medicine, vol.163, issue.8, pp.901-908, 2003. ,
DOI : 10.1001/archinte.163.8.901
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran, American Heart Journal, vol.157, issue.5, pp.805-815, 2009. ,
DOI : 10.1016/j.ahj.2009.02.005
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism, New England Journal of Medicine, vol.361, issue.24, pp.2342-2352, 2009. ,
DOI : 10.1056/NEJMoa0906598
URL : https://hal.archives-ouvertes.fr/ujm-00439704
Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate, Clinical Pharmacokinetics, vol.5, issue.1, pp.285-295, 2008. ,
DOI : 10.2165/00003088-200847050-00001
Rivaroxaban Once daily oral direct Factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and embolism Trial in Atrial Fibrillation, N Eng J Med, vol.365, pp.883-891, 2011. ,
Oral rivaroxban for symptomatic venous thromboembolism, N Engl J Med, vol.363, pp.2499-2510, 2010. ,
Questions???????r??ponses sur l???utilisation du rivaroxaban pour le traitement de la maladie thromboembolique veineuse, Journal des Maladies Vasculaires, vol.37, issue.6, pp.300-310, 2012. ,
DOI : 10.1016/j.jmv.2012.09.003
The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in??vitro study, Journal of Thrombosis and Haemostasis, vol.8, issue.1, pp.226-228, 2011. ,
DOI : 10.1111/j.1538-7836.2010.04106.x
Oral Anticoagulant Therapy, Chest, vol.141, issue.2, pp.44-88, 2012. ,
DOI : 10.1378/chest.11-2292
Recombinant antidote for reversal of anticoagulation by factor Xa inhibitors, Blood, vol.112, 2008. ,
Effect of nonspecific reversal agents on anticoagulant activity of dabigatran and rivaroxaban. A randomised crossover ex vivo study in healthy volunteers, Thromb Haemost, 2012. ,
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa, Nature medicine, vol.19, pp.446-453, 2013. ,
DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS, Journal of the American College of Cardiology, vol.57, issue.14, 1130. ,
DOI : 10.1016/S0735-1097(11)61130-3
Dabigatran etexilate ??? a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity, Thrombosis and Haemostasis, vol.103, issue.6, pp.1116-1127, 2010. ,
DOI : 10.1160/TH09-11-0758
Effects of Agents, Used to Treat Bleeding Disorders, on Bleeding Time Prolonged by a Very High Dose of a Direct Thrombin Inhibitor in Anesthesized Rats and Rabbits, Thrombosis Research, vol.101, issue.3, pp.159-170, 2001. ,
DOI : 10.1016/S0049-3848(00)00398-4
Recombinant Factor VIIa to Manage Major Bleeding from Newer Parenteral Anticoagulants, Annals of Pharmacotherapy, vol.44, issue.4, pp.718-726, 2010. ,
DOI : 10.1345/aph.1M447
Safety of Recombinant Activated Factor VII in Randomized Clinical Trials, New England Journal of Medicine, vol.363, issue.19, pp.1791-1800, 2010. ,
DOI : 10.1056/NEJMoa1006221
Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement, Thrombosis Research, vol.127, issue.5, pp.455-467, 2011. ,
DOI : 10.1016/j.thromres.2011.01.001
Controversies in Perioperative Management of Blood Thinners in Dermatologic Surgery, Dermatologic Surgery, vol.30, issue.8, pp.1091-1094, 2004. ,
DOI : 10.1097/00042728-200408000-00005
Complications of Cutaneous Surgery in Patients Who Are Taking Warfarin, Aspirin, or Nonsteroidal Anti-inflammatory Drugs, Archives of Dermatology, vol.132, issue.2, pp.161-166, 1996. ,
DOI : 10.1001/archderm.1996.03890260063009
Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin and nonsteroidal anti-inflammatory agents: a prospective study, Dermatol Surg, vol.23, pp.381-385, 1997. ,
Prise en charge des patients sous anticoagulants ou sous agents antiplaquettaires avant une endoscopie digestive, 2005. ,
Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants, The American Journal of Gastroenterology, vol.122, issue.7, pp.1717-1725, 2000. ,
DOI : 10.1056/NEJM199304013281301
For American Society for Gastrointestinal Endoscopy ,
The new oral anticoagulants: practical management for patients attending for endoscopic procedures, Frontline Gastroenterology, vol.107, issue.3, pp.213-218, 2013. ,
DOI : 10.1136/flgastro-2013-100325
Recommandation pour la prise en charge des patients sous AVK en chirurgie bucco-dentaire, Médecine buccale chirurgie buccale, vol.12, pp.187-206, 2006. ,
chirurgie de la cataracte sous anticoagulant ou antiagrégant : anesthésie topique et sous tenonienne, J Fr Ophtalmol, vol.25, pp.130-132, 2002. ,
Risks and Benefits of Anticoagulant and Antiplatelet Medication Use before Cataract Surgery, Ophtalmology, vol.110, pp.1784-1788, 2003. ,
Phacoemulsification and lens implantation in patients treated with aspirin or warfarin, Journal of Cataract & Refractive Surgery, vol.24, issue.10, pp.1361-1364, 1998. ,
DOI : 10.1016/S0886-3350(98)80229-0
A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium, Arthritis & Rheumatism, vol.27, issue.4, pp.736-739, 1998. ,
DOI : 10.1002/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P
Antiagr??gants, anticoagulants et infiltrations??: comment faire???, Revue du Rhumatisme, vol.69, issue.1, pp.8-11, 2002. ,
DOI : 10.1016/S1169-8330(01)00241-1